The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaspian Sunrise Regulatory News (CASP)

Share Price Information for Caspian Sunrise (CASP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.35
Bid: 3.30
Ask: 3.40
Change: 0.00 (0.00%)
Spread: 0.10 (3.03%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.35
CASP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shareholding Update

4 Aug 2017 16:12

RNS Number : 1999N
Caspian Sunrise plc
04 August 2017
 

 

Caspian Sunrise PLC ("Caspian Sunrise" or the "Company")

formerly Roxi Petroleum Plc

 

Shareholding update

 

Introduction

 

Caspian Sunrise PLC (formerly Roxi Petroleum plc) ("Caspian Sunrise"), the Central Asian oil and gas company, with a focus on Kazakhstan, has been informed of the following changes in the shareholdings of the Company.

 

On completion of the Baverstock Merger 651,436,544 new Caspian Sunrise shares of 1 pence each ("Shares") were issued to Baverstock GmbH ("Baverstock"). These together with their existing 98,000,000 Shares in Caspian Sunrise brought the total shareholding of Baverstock to 749,436,544 (44.9%). The total number Shares in issue were then and remain 1,669,673,820.

 

As previously announced to aid transparency it is planned that the four Baverstock Quota-holders split out their individual holdings pro rata to their individual interests in Baverstock.

 

While work to allow this to happen continues Baverstock has sold 11,922,500 Shares at a price of 10 pence per Share from the effective interests of one of the Quota-holders, Mr Dosbol Zholdybayev, who had a 13.61% interest in Baverstock.

 

This reduces Mr Zholdybayev's effective holding in the Company from 101,998,314 shares (6.11%) to 90,075,814 shares (5.4%) and reduces Baverstock's interest from 749,436,544 shares (44.9%) to 737,516,044 shares (44.2%).

 

For the avoidance of doubt all the other Baverstock Quota-holders effective interests in Caspian Sunrise, including those of the Caspian Sunrise CEO Kuat Oraziman, remain unchanged.

 

Ends

 

Caspian Sunrise PLC

 

Clive Carver

Executive Chairman

+7 727 375 0202

 

 

WH Ireland, Nominated Adviser & Broker

 

James Joyce

James Bavister

+44 (0) 207 220 1666

 

 

Abchurch Communications

 

Tim Thompson

+44 (0) 207 398 7719

CaspianSunrise@abchurch-group.com

 

 

 

 

This announcement has been posted to:

www.caspiansunrise.com/investors

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGURURUPMGAC
Date   Source Headline
25th Apr 20241:08 pmRNSGeneral Meeting Results
24th Apr 20247:00 amRNSIssue of Equity and Option Awards
8th Apr 20247:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
25th Mar 20247:00 amRNSStrategic & Operational Update
16th Feb 20247:00 amRNSBNG Operational update
21st Dec 20237:00 amRNSOperational Update
31st Oct 20237:00 amRNSOperational update
25th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 202312:49 pmRNSGM results
31st Jul 20237:00 amRNSGeneral Meeting & BNG and Caspian Explorer updates
11th Jul 202312:50 pmRNSHolding(s) in Company
10th Jul 20237:00 amRNSBoard change, Posting of the 2022 Results
7th Jul 20237:30 amRNSRestoration- Caspian Sunrise plc
7th Jul 20237:00 amRNSAnnual Report for the Year Ended 31 December 2022
3rd Jul 20237:30 amRNSSuspension - Caspian Sunrise plc
30th Jun 20233:51 pmRNSAGM results
30th Jun 20237:00 amRNSAGM Statement
12th Jun 20237:00 amRNS50% Sale of Caspian Explorer & Operational Update
1st Jun 20239:26 amRNSAGM and 2022 Accounts update
7th Mar 20237:00 amRNSCaspian Explorer contract signed & Dividend update
20th Feb 20237:00 amRNSCaspian Explorer update & Dividend update
30th Jan 20237:00 amRNSDeep well update
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
16th Jan 202311:05 amRNSSecond Price Monitoring Extn
16th Jan 202311:00 amRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSTender Update
12th Jan 20237:00 amRNSThird Monthly Dividend Declaration
22nd Dec 20228:14 amRNSOperational Update
5th Dec 20227:00 amRNSSecond Monthly Dividend Declaration
11th Nov 20227:00 amRNSDividend Details
7th Nov 202211:05 amRNSSecond Price Monitoring Extn
7th Nov 202211:00 amRNSPrice Monitoring Extension
4th Nov 20224:40 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 20227:00 amRNSOperational Update and Dividend Declaration
3rd Oct 20224:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:36 pmRNSPrice Monitoring Extension
26th Sep 202210:14 amRNSReplacement Announcement for Interim Results
26th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
11th Aug 20227:00 amRNSResult of GM
30th Jun 20222:21 pmRNSResult of AGM
30th Jun 20228:53 amRNSOraziman family holdings
27th Jun 20227:00 amRNSAnnual Report and Financial Statements
22nd Jun 20228:32 amRNSUK High Court confirms Capital Reduction
6th Jun 20227:00 amRNSOperational and impact of Russian sanctions update
31st May 20227:00 amRNSNotice of AGM
30th May 20227:00 amRNSUK Oil Company Windfall Tax & Dividend Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.